Loading
Latest filing published 04 Jun 2026 for Keros Therapeutics, Inc., €24k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Our data holds just one disclosure by Farzan Nima, dated 4 June 2026, reporting a transaction worth €24k in Keros Therapeutics, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration